Shareholder alert: ademi llp investigates whether acer therapeutics inc. has obtained a fair price in its transaction with zevra

Milwaukee , aug. 31, 2023 /prnewswire/ -- ademi llp is investigating acer (nasdaq: acer) for possible breaches of fiduciary duty and other violations of law in its transaction with zevra. click here to learn how to join the action https://www.ademilaw.com/case/acer-therapeutics-inc or call guri ademi toll-free at 866-264-3995.
ACER Ratings Summary
ACER Quant Ranking